# Carter BloodCare – FDA Inspection, Dec 6, 2017

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/5b928782-bdfe-46a1-84fb-78e39dcb3cf5
Source feed: FDA_Inspections

> FDA inspection 1033975 of Carter BloodCare, December 06, 2017. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 606 and 640. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1033975
- Company Name: Carter BloodCare
- Inspection Date: 2017-12-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1217918 - 2023-08-22
- FDA Inspection 1093449 - 2019-04-12
- FDA Inspection 846717 - 2013-08-29
- [FDA Inspection 736481 - 2011-07-27](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/496721d8-2462-46d6-8502-3ae33bf60da4)
- FDA Inspection 604811 - 2009-08-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/decarlos-a-gomez/4b003235-edbb-4cb5-acb1-4e154941578c)
- [Issuing Officer](https://www.keypedia.com/people/elmina-e-akwo/ecd9066d-1647-4765-ad86-dbe5280241c5)
- [Issuing Officer](https://www.keypedia.com/people/william-f-lagud/c90c4bd6-bb56-4a60-a5f8-cbc648bb8dbe)

Company: https://www.keypedia.com/companies/carter-bloodcare/1110476b-aead-4d21-99d5-13411d4ba96f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d